To further explore the role of HMGB1 on liver lipid synthesis, and firmly establish HMGB1 as a potent candidate to repress liver steatosis, we set up a gain-of-function model where HMGB1 is overexpressed in vivo using adeno-associated virus (AAV)–mediated gene transfer. Here, HMGB1 is linked to fatty liver disease.